Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors

被引:36
作者
Dirix, L. Y. [1 ]
Maes, H. [1 ]
Sweldens, C. [1 ]
机构
[1] AZ Sint Augustinus Canc Ctr, B-2610 Antwerp, Belgium
关键词
D O I
10.1093/annonc/mdm205
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1121 / 1122
页数:2
相关论文
共 5 条
  • [1] Vascular endothelial growth factor in ischemia for vascular angiogenesis
    Henry, TD
    Annex, BH
    McKendall, GR
    Azrin, MA
    Lopez, JJ
    Giordano, FJ
    Shah, PK
    Willerson, JT
    Benza, RL
    Berman, DS
    Gibson, CM
    Bajamonde, A
    Rundle, AC
    Fine, J
    McCluskey, ER
    [J]. CIRCULATION, 2003, 107 (10) : 1359 - 1365
  • [2] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2335 - 2342
  • [3] Mechanisms of hypertension associated with BAY 43-9006
    Veronese, ML
    Mosenkis, A
    Flaherty, KT
    Gallagher, M
    Stevenson, JP
    Townsend, RR
    O'Dwyer, PJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) : 1363 - 1369
  • [4] Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension
    Vyzantiadis, Timoleon
    Karagiannis, Asterios
    Douma, Stella
    Harsoulis, Phaedon
    Vyzantiadis, Athanasios
    Zamboulis, Chrysanthos
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2006, 28 (07) : 603 - 609
  • [5] A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
    Yang, JC
    Haworth, L
    Sherry, RM
    Hwu, P
    Schwartzentruber, DJ
    Topalian, SL
    Steinberg, SM
    Chen, HX
    Rosenberg, SA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) : 427 - 434